IBI110,Sintilimab
eli lilly,Innovent Biologics
['ibi110', '$ivbxf', 'innovent']
$ivbxf innovent presents phase 1b clinical data of ibi110 (anti-lag-3 monoclonal antibody) at the 2023 asco annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities